Glibenclamide treatment in permanent neonatal diabetes mellitus due to an activating mutation in Kir6.2. (Q45142819)
Jump to navigation
Jump to search
scientific article published in November 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Glibenclamide treatment in permanent neonatal diabetes mellitus due to an activating mutation in Kir6.2. |
scientific article published in November 2004 |
Statements
1 reference
Glibenclamide treatment in permanent neonatal diabetes mellitus due to an activating mutation in Kir6.2. (English)
1 reference
Amnon Zung
1 reference
Benjamin Glaser
1 reference
Revital Nimri
1 reference
Zvi Zadik
1 reference
1 November 2004
1 reference
1 reference
89
1 reference
11
1 reference
5504-5507
1 reference
Identifiers
1 reference
1 reference